v3.26.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenues $ 730,571 $ 535,060 $ 1,083,946 $ 1,088,880
Cost of revenues 425,844 371,796 716,335 759,822
Gross profit 304,727 163,264 367,611 329,058
Operating expenses:        
Sales, general and administrative 1,291,318 814,811 2,644,076 1,615,955
Research and development 257,632 194,124 411,114 330,955
Total operating expenses 1,548,950 1,008,935 3,055,190 1,946,910
Operating loss (1,244,223) (845,671) (2,687,579) (1,617,852)
Other (expense) income:        
Interest expense (272,245) (935) (539,254) (1,675)
Interest income 14,476 5,673 21,129 14,131
Loss on change in fair value of warrant liability (148,766)
Loss on issuance of convertible note (4,236) (326,595)
Other expense, net (115) (115) (115)
Total other (expense) income (262,120) 4,738 (993,601) 12,341
Provision for income taxes
Net loss (1,506,343) (840,933) (3,681,180) (1,605,511)
Deemed dividend on warrant modifications (1,124,676) (1,124,676)
Preferred stock dividends (121,662) (175,854)
Net loss attributable to common stockholders $ (2,752,681) $ (840,933) $ (4,981,710) $ (1,605,511)
Basic net loss per common share (in Dollars per share) $ (0.26) $ (0.17) $ (0.54) $ (0.33)
Diluted net loss per common share (in Dollars per share) $ (0.26) $ (0.17) $ (0.54) $ (0.33)
Weighted-average common shares outstanding, basic (in Shares) 10,790,722 4,823,125 9,230,710 4,823,125
Weighted-average common shares outstanding, diluted (in Shares) 10,790,722 4,823,125 9,230,710 4,823,125